1 year return (CAGR)
-16.43%
Foghorn Therapeutics Inc Exchange (NASDAQ, USD)
FHTX
4.17
+0.05 (+1.21%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-18.03%
5 year return (CAGR)
-20.09%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
247.64M
Price/Sales
6.74
Ent value
463.99M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
185.67%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.17 |
| Daily high | 4.23 |
| Daily low | 4.08 |
| Daily Volume | 355K |
| All-time high | 25.88 |
| 1y analyst estimate | 11.44 |
| Beta | 2.83 |
| EPS (TTM) | -0.91 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| FHTX | S&P500 | |
| Current price drop from All-time high | -83.89% | -3.06% |
| Highest price drop | -89.10% | -56.47% |
| Date of highest drop | 5 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -66.75% | -10.68% |
| Avg time to new high | 165 days | 12 days |
| Max time to new high | 1441 days | 1805 days |
News
